Health News Sotrovimab cuts risk for COVID-19 progression in high-risk patients 10/29/2021 (HealthDay)—Sotrovimab reduces the risk for disease progression in high-risk patients with mild-to-moderate COVID-19, according to a study published online Oct. 27 in the New England Journal of Medicine. Read More